[Inoa Latina] Griffonia simplicifolia

[Plant Source] Hua Griffonia

[Nā kikoʻī] 98%; 99% HPLC

[Hōʻike] pauda maikaʻi keʻokeʻo

Māhele Mea kanu: Hua

[Particle nui] 80 Mesh

[Nalo ma ka maloʻo] ≤5.0%

[Mea Kaumaha] ≤10PPM

[Ke koena pesticide] EC396-2005, USP 34, EP 8.0, FDA

[Storage] E kūʻai ma kahi maloʻo a maloʻo, e mālama i ka mālamalama pololei a me ka wela.

[Ke ola mau] 24 Mahina

[Package] Hoʻopili ʻia i loko o nā pahu pahu pepa a me ʻelua ʻeke plastik i loko.

[Kapaona paona] 25kgs/pahu

[He aha ka 5-HTP]

ʻO ka 5-HTP (5-Hydroxytryptophan) he mea hoʻohana kemika o ka poloka kūkulu hale protein L-tryptophan. Hoʻohana ʻia ia ma ke kālepa mai nā hua o kahi mea kanu ʻApelika i kapa ʻia ʻo Griffonia simplicifolia 5-HTP i hoʻohana ʻia no nā maʻi hiamoe e like me ka insomnia, ke kaumaha, ka hopohopo, ka migraine a me ke ʻano o ke poʻo o ke ʻano, fibromyalgia, obesity, premenstrual syndrome (PMS), premenstrual. dysphoric disorder (PMDD), attention deficit-hyperactivity disorder (ADHD), seizure disorder, a me ka maʻi o Parkinson.

[Pehea ka hana?]

Hana ʻo 5-HTP i loko o ka lolo a me ka ʻōnaehana nūnū waena ma o ka hoʻonui ʻana i ka hana ʻana o ka serotonin kemika. Hiki i ka Serotonin ke hoʻopilikia i ka hiamoe, ka ʻai, ka mahana, ka moe kolohe, a me ka ʻeha. Ma muli o ka hoʻonui ʻana o 5-HTP i ka synthesis o ke serotonin, hoʻohana ʻia ia no nā maʻi he nui kahi i manaʻoʻiʻo ʻia ai ka serotonin e hana koʻikoʻi me ke kaumaha, insomnia, obesity, a me nā kūlana ʻē aʻe.

[Hana]

Ke kaumaha. Hōʻike kekahi mau noiʻi lapaʻau i ka lawe ʻana i ka 5-HTP ma ka waha e hoʻomaikaʻi i nā hōʻailona o ke kaumaha i kekahi poʻe. Ke hōʻike nei kekahi mau noiʻi lāʻau lapaʻau ʻo ka lawe ʻana i ka 5-HTP ma ka waha e like me ka maikaʻi e like me kekahi mau lāʻau antidepressant kauoha no ka hoʻomaikaʻi ʻana i nā hōʻailona kaumaha. I ka nui o nā haʻawina, ua lawe ʻia ka 150-800 mg i kēlā me kēia lā o 5-HTP. I kekahi mau hihia, ua hoʻohana ʻia nā kiʻi kiʻekiʻe.

Down syndrome. Hōʻike kekahi mau noiʻi ʻo ka hāʻawi ʻana i ka 5-HTP i nā pēpē me Down syndrome e hoʻomaikaʻi i ka ʻiʻo a me ka hana. Hōʻike nā noiʻi ʻē aʻe ʻaʻole ia e hoʻomaikaʻi i ka ʻiʻo a i ʻole ka ulu ʻana ke lawe ʻia mai ka wā kamaliʻi a hiki i 3-4 mau makahiki. Hōʻike pū ka noiʻi ʻo ka lawe ʻana i ka 5-HTP me nā lāʻau lapaʻau maʻamau e hoʻomaikaʻi i ka hoʻomohala ʻana, nā mākau pilikanaka, a i ʻole nā ​​mākau ʻōlelo.

Hopohopo  Ua ʻike ʻia ʻo 5-HTP e pale aku i ka hoʻouka kaua panic i hoʻokomo ʻia e carbon dioxide. Hoʻokahi haʻawina i hoʻohālikelike i ka 5-HTP a me ka lāʻau lapaʻau clomipramine no ka hopohopo. ʻO Clomipramine kahi antidepressant tricyclic i hoʻohana ʻia no ka mālama ʻana i ka maʻi obsessive-compulsive. Ua ʻike ʻia ʻo 5-HTP he mea maikaʻi loa ia i ka hōʻemi ʻana i nā hōʻailona hopohopo, akā ʻaʻole maikaʻi e like me ka clomipramine.

Moe Ua ʻoi aku ka maikaʻi o nā mea hoʻohui 5-HTP no ka insomnia. Ua hoʻemi ʻo 5-HTP i ka manawa e pono ai e hiamoe a hoʻemi i ka helu o nā ala ala pō. ʻO ka lawe ʻana i ka 5-HTP me GABA (gamma-aminobutyric acid), kahi neurotransmitter hoʻomaha, hoʻemi i ka manawa e hiamoe ai a hoʻonui i ka lōʻihi a me ka maikaʻi o ka hiamoe. Ua ʻike ʻia kahi haʻawina ua loaʻa i nā keiki me ka weliweli pō ka 5-HTP.

Nā hana hoʻoikaika kino o ka ʻōpū microbiome i ke olakino a me ka maʻi

Ka lā hoʻolele: Poalua, ʻOkakopa 27, 2015, 3:00:00 PM

Māhele: WALS - Nā Haʻawina ahiahi Pōʻakolu

Ka manawa holo: 01:00:59

ʻO ka wehewehe: ʻO ka NIH Director's Wednesday Afternoon Lecture Series

ʻO ka noiʻi noiʻi o Dr. Fraser i kēia manawa ua kālele ʻia i ke ʻano o ke ʻano a me ka hana o nā kaiāulu microbial i ʻike ʻia i loko o ke kaiapuni kanaka, ma ke ʻano he ʻāpana o ka HumanMicrobiome Project i kākoʻo ʻia e NIH, me nā papahana e pili pono ana i ka obesity, metabolic syndrome, inflammatory bowel maʻi, ka nā pilina ma waena o ka pane ʻana o ke kanaka a me ka microbiome o ka ʻōpū, a me ka hopena o nā probiotics i ke ʻano a me ka hana o ka microbiome intestinal.

E pili ana i ka haʻi ʻōlelo makahiki ʻo Rolla E. Dyer:

Hōʻike ka Rolla E. Dyer Lecture i ka mea noiʻi kaulana kaulana i hāʻawi nui i ka lāʻau lapaʻau a me ka ʻike olaola o nā maʻi maʻi. Hoʻokumu ʻia i ka makahiki 1950, hoʻohanohano ka papa haʻiʻōlelo i ka luna NIH mua ʻo Dr. Dyer, ka mea i koho ʻia i ka mana no nā maʻi maʻi.

No ka ʻike hou aku e hele i https://oir.nih.gov/wals

Mea kākau: Claire Fraser, Ph.D., Kumu o ka Lapaʻau, Microbiology and Immunology; Luna Hoʻokele, Institute for Genome Sciences; Ke Kula Lapaʻau o ke Kulanui o Maryland

Loulou mau: https://videocast.nih.gov/launch.asp?19272

www.anthogenol.at